451 related articles for article (PubMed ID: 34677370)
1. Physiological and Pathological Roles of Aldose Reductase.
Singh M; Kapoor A; Bhatnagar A
Metabolites; 2021 Sep; 11(10):. PubMed ID: 34677370
[TBL] [Abstract][Full Text] [Related]
2. The role of aldose reductase in polyol pathway: An emerging pharmacological target in diabetic complications and associated morbidities.
Gupta JK
Curr Pharm Biotechnol; 2023 Aug; ():. PubMed ID: 37649296
[TBL] [Abstract][Full Text] [Related]
3. Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems.
Niimi N; Yako H; Takaku S; Chung SK; Sango K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494154
[TBL] [Abstract][Full Text] [Related]
4. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions.
Sonowal H; Ramana KV
Curr Med Chem; 2021; 28(19):3683-3712. PubMed ID: 33109031
[TBL] [Abstract][Full Text] [Related]
5. ALDOSE REDUCTASE: New Insights for an Old Enzyme.
Ramana KV
Biomol Concepts; 2011 Apr; 2(1-2):103-114. PubMed ID: 21547010
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase: a novel therapeutic target for inflammatory pathologies.
Ramana KV; Srivastava SK
Int J Biochem Cell Biol; 2010 Jan; 42(1):17-20. PubMed ID: 19778627
[TBL] [Abstract][Full Text] [Related]
7. [Aldose reductase in the polyol pathway: a potential target for the therapeutic intervention of diabetic complications].
Nishimura-Yabe C
Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):137-45. PubMed ID: 9583077
[TBL] [Abstract][Full Text] [Related]
8. In Search of Differential Inhibitors of Aldose Reductase.
Balestri F; Moschini R; Mura U; Cappiello M; Del Corso A
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454074
[TBL] [Abstract][Full Text] [Related]
9. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
Srivastava SK; Ramana KV; Bhatnagar A
Endocr Rev; 2005 May; 26(3):380-92. PubMed ID: 15814847
[TBL] [Abstract][Full Text] [Related]
10. Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review.
Grewal AS; Thapa K; Kanojia N; Sharma N; Singh S
Curr Drug Metab; 2020; 21(14):1091-1116. PubMed ID: 33069193
[TBL] [Abstract][Full Text] [Related]
11. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase, oxidative stress, and diabetic mellitus.
Tang WH; Martin KA; Hwa J
Front Pharmacol; 2012; 3():87. PubMed ID: 22582044
[TBL] [Abstract][Full Text] [Related]
13. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
Suzen S; Buyukbingol E
Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase, still a compelling target for diabetic neuropathy.
Oates PJ
Curr Drug Targets; 2008 Jan; 9(1):14-36. PubMed ID: 18220710
[TBL] [Abstract][Full Text] [Related]
15. A spontaneously immortalized Schwann cell line from aldose reductase-deficient mice as a useful tool for studying polyol pathway and aldehyde metabolism.
Niimi N; Yako H; Takaku S; Kato H; Matsumoto T; Nishito Y; Watabe K; Ogasawara S; Mizukami H; Yagihashi S; Chung SK; Sango K
J Neurochem; 2018 Mar; 144(6):710-722. PubMed ID: 29238976
[TBL] [Abstract][Full Text] [Related]
16. Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.
Jannapureddy S; Sharma M; Yepuri G; Schmidt AM; Ramasamy R
Front Endocrinol (Lausanne); 2021; 12():636267. PubMed ID: 33776930
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aldose reductase and the polyol pathway activity by nitric oxide.
Srivastava SK; Ramana KV; Chandra D; Srivastava S; Bhatnagar A
Chem Biol Interact; 2003 Feb; 143-144():333-40. PubMed ID: 12604220
[TBL] [Abstract][Full Text] [Related]
18. A new approach to control the enigmatic activity of aldose reductase.
Del-Corso A; Balestri F; Di Bugno E; Moschini R; Cappiello M; Sartini S; La-Motta C; Da-Settimo F; Mura U
PLoS One; 2013; 8(9):e74076. PubMed ID: 24019949
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and structural characterization of the glutathione-binding site of aldose reductase.
Dixit BL; Balendiran GK; Watowich SJ; Srivastava S; Ramana KV; Petrash JM; Bhatnagar A; Srivastava SK
J Biol Chem; 2000 Jul; 275(28):21587-95. PubMed ID: 10764810
[TBL] [Abstract][Full Text] [Related]
20. Structural and kinetic determinants of aldehyde reduction by aldose reductase.
Srivastava S; Watowich SJ; Petrash JM; Srivastava SK; Bhatnagar A
Biochemistry; 1999 Jan; 38(1):42-54. PubMed ID: 9890881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
